声明：本系列文章基于原期刊目录和摘要内容整理而得，仅限于读者交流学习。如有侵权，请联系 删除。 期刊介绍： 《Journal of Health Economics》（《健康经济学杂志》）是一本专注于健康和医疗保健经济学领域 的学术期刊。该期刊成立于1982年，它涉及的主题包括健康服务的生产和供应、健康服务的需求和 利用、健康服务的融资、健康的决定因素（包括健康投资和风险健康行为）、疾病不良后果、需求 者、供应者和其他卫生保健机构的行为模型、政策干预的评估以及卫生政策的效率和分配等方面。 该刊每年发行6期，平均每期发表文章10篇左右，2024年影响因子为3.4。 本期看点： ●宽带互联网接入使年轻群体（1985年至1995年出生）的精神障碍患病率提高了0.08个标准差单 位，但对年长个体（1974年至1984年出生）没有影响。这种负面影响主要出现在生命早期（20岁之 前）接触互联网的群体中。 ●关联寻求行为偏好与生活质量优于财富的相对偏好，共同解释了长期护理保险参保率偏低的现 象。 ●美国劳动所得税抵免（EITC）政策总体上促进了代际健康流动性的提升，特别是向上的健康流动 性。 作者 ●疗养院工资补贴使人员配 ...

NEW YORK, Nov. 01, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Molina Healthcare, Inc. (NYSE: MOH) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Molina, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/molina-healthcare-inc-class-action. Investors have until December 2, 2025, to ask the Court to be appoin ...

Minerva Studio/iStock via Getty Images Shares in US health insurers struggled after the release of third quarter results, which were marked by rising costs and political uncertainty. Of the five largest publicly traded US managed care insurers, all but Humana ...

Wall Street analysts expect Humana (HUM) to post quarterly earnings of $2.91 per share in its upcoming report, which indicates a year-over-year decline of 30.1%. Revenues are expected to be $31.98 billion, up 9.1% from the year-ago quarter.The current level reflects a downward revision of 2.3% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.Prior to a company's ...

With 5.5 million members across 29 states, Ambetter Health continues its legacy of delivering affordable, accessible coverage through Centene Corporation's national network. ST. LOUIS, Oct. 31, 2025 /PRNewswire/ -- As the Marketplace open enrollment begins, Ambetter Health, the health insurance product offered by Centene Corporation (NYSE: CNC) subsidiaries, a leading healthcare enterprise committed to helping people live healthier lives, proudly marks its 13th year on the Health Insurance Marketplace. O ...

Alignment Healthcare (NasdaqGS:ALHC) Q3 2025 Earnings Call October 30, 2025 05:00 PM ET Speaker4Good afternoon, and welcome to Alignment Healthcare's third quarter 2025 earnings conference call and webcast. All participants will be in a listen-only mode. After today's presentation, there will be an opportunity to ask questions. Please note that this event is being recorded. Leading today's call are John Kao, Founder and CEO, and Jim Head, Chief Financial Officer. Before we begin, we would like to remind you ...

Alignment Healthcare Thursday reported its second consecutive profitable quarter as a publicly-traded company in part by managing medical expenses better than many of its rivals who sell Medicare Advantage coverage to older adults.Alignment HealthcareAlignment Healthcare reported its second consecutive profitable quarter as a publicly trade company in part by managing medical expenses better than many of its rivals who sell Medicare Advantage coverage to older adults. Alignment, which reported third quarter ...

NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Molina Healthcare, Inc. (NYSE: MOH) between February 5, 2025 and July 23, 2025, both dates inclusive (the “Class Period”), of the important December 2, 2025 lead plaintiff deadline. SO WHAT: If you purchased Molina securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. ...

Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit and adjusted EBITDAHas 100% of members in plans rated 4 stars or higher for second consecutive year in 2026, including two 5-star contracts in Nevada and North Carolina and a 4.5-star contract in Texas ORANGE, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), today reported fina ...

评级与目标价调整 - RBC Capital将CVS Health评级上调至“跑赢大盘”，股价为76.68美元 [1] - RBC Capital将公司目标价从81美元大幅提升至93美元 [1] 第三季度财务业绩 - 第三季度销售额达到1028.7亿美元，超出市场共识预期的988.4亿美元 [2] - 总营收同比增长7.8%，所有业务部门均实现增长 [2] - 尽管因57亿美元商誉减值导致GAAP摊薄后每股亏损3.13美元，但调整后每股收益为1.60美元，超过分析师预期的1.37美元 [3] - 调整后营业利润大幅增长35.8%，达到34.6亿美元，主要得益于健康保险业务部门的增长 [3] 业务发展与市场表现 - 公司计划与EMD Serono合作，于2026年推出TrumpRx生育计划 [4] - 股价在公布业绩后触及52周新高，当前股价为76.81美元，当日下跌4.70%或3.79美元，交易区间为75.92美元至79美元 [2][4] - 公司52周股价区间为43.56美元至85.15美元，当前市值约为974.2亿美元 [4]